MUSIC at AUA 2023

Title of Abstract	Time	Room
External Validation of Decreased ED Visits due to Quality Improvement Initiatives of a Statewide Collaborative	7:00 - 9:00 AM	S 505
Practice-Level Variation in Opioid-Free Discharge Following Surgery for T1 Renal Masses: A MUSIC-KIDNEY Analysis	9:30 - 11:30 AM	S 502
Roadmap for treating small renal masses in Michigan: A patient advocate’s story	1:25 - 1:40 PM	Booth 232
Daily Ecological Momentary Assessments of Pain and Ability to Work after Ureteroscopy and Stenting	3:30 - 5:50 PM	S 401
Stone Location and Stenting Influence Patient-Reported Pain and Quality of Life after Ureteroscopy	3:30 - 5:50 PM	S 401

Title of Abstract	Time	Room
Assessing the generalizability of randomized evidence by comparing results from a clinical trial and established quality improvement collaborative: results from G-MINOR and MUSIC	1:00 - 3:00 PM	S 502
Upgrading on Per Protocol vs For Cause Surveillance Prostate Biopsies: An Opportunity to Decreasing the Burden of Active Surveillance	1:00 - 3:00 PM	S 403
Discontinuation of Active Surveillance Without Risk Reclassification Prior to Treatment	1:00 - 3:00 PM	S 403
Assessing Utilization Renal Mass Biopsy in the Management of T1a vs. T1b Renal Masses	1:00 - 3:00 PM	S 504
The Effect of Opiates on Patient Reported Outcomes After Ureteroscopy	3:30 - 5:30 PM	S 505
Can MRI Replace Repeat Biopsy in the Evaluation of Men with Multifocal High Grade Prostatic Intraepithelial Neoplasia and Atypical Small Acinar Proliferation?	3:30 - 5:30 PM	S 403
MUSIC Reception	5:00 - 7:00 PM	Marriott Marquis Chicago Grand Horizon G

Title of Abstract	Time	Room
Lower rates of clinically-significant prostate cancer are present in PI-RADS 4 and 5 lesions in the transitional zone than peripheral zone	9:30 - 11:30 AM	S 403
Stents and Shockwave Lithotripsy - the Who and the Why: Results from a Statewide Collaborative	9:30 - 11:30 AM	S 401
Ureteroscopy Dusting versus Fragmentation/Basketing for Treating Renal Stones: Real World Utilization and Outcomes	9:30 - 11:30 AM	S 401
Dueling Active Surveillance: Does Utilization of Active Surveillance for Low Risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?	1:00 - 3:00 PM	S 504
The Patient’s Voice at Scale: Understanding Why Patients are Not Sexually Active Post Radical Prostatectomy Through Qualitative Coding of Responses on a Patient Reported Outcome Instrument	1:00 - 3:00 PM	S 404
Three-Year Follow-Up for Surveillance of T1 Renal Masses: A MUSIC-KIDNEY Analysis	1:00 - 3:00 PM	S 504
Early Secondary Treatment of Lymph Node Positive Prostate Cancer after Radical Prostatectomy is Associated with Aggressive Tumor Features and Detectable Prostate Specific Antigen	1:00 - 3:00 PM	S 403
Negative Predictive Value of Prostate MRI in Real World Practice: Results from a Statewide Surgical Collaborative	3:30 - 5:30 PM	S 502
Is Routine Antibiotic Prophylaxis Required for Transperineal Prostate Biopsy?	3:30 - 5:30 PM	S 502

Title of Abstract	Time	Room
Practice and provider-level variation in the surgical management of T1a renal masses: results from a statewide collaborative	7:00 - 9:00 AM	S 404
Does the Use of a Ureteral Access Sheath Reduce Infection-Related Hospitalization? Real-World Data from a Surgical Collaborative	1:00 - 3:00 PM	S 401
Management of Biochemical Recurrence After Prostatectomy Within the MUSIC Collaborative	1:00 - 3:00 PM	S 504